Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 443

1.

An observational study of outcome in SLE patients with biopsy-verified glomerulonephritis between 1986 and 2004 in a defined area of southern Sweden: the clinical utility of the ACR renal response criteria and predictors for renal outcome.

Nived O, Hallengren CS, Alm P, Jönsen A, Sturfelt G, Bengtsson AA.

Scand J Rheumatol. 2013;42(5):383-9. doi: 10.3109/03009742.2013.799224. Epub 2013 Jul 5.

PMID:
23829689
2.

The prognosis and pathogenesis of severe lupus glomerulonephritis.

Schwartz MM, Korbet SM, Lewis EJ; Collaborative Study Group.

Nephrol Dial Transplant. 2008 Apr;23(4):1298-306. Epub 2007 Nov 28.

PMID:
18045825
3.

Interstitial inflammation and long-term renal outcomes in lupus nephritis.

Alsuwaida AO.

Lupus. 2013 Dec;22(14):1446-54. doi: 10.1177/0961203313507986. Epub 2013 Oct 4.

PMID:
24097970
4.
5.

Analysis of clinicopathologic correlations in Iranian patients with lupus nephritis.

Shariati-Sarabi Z, Ranjbar A, Monzavi SM, Esmaily H, Farzadnia M, Zeraati AA.

Int J Rheum Dis. 2013 Dec;16(6):731-8. doi: 10.1111/1756-185X.12059. Epub 2013 May 28.

PMID:
24382282
6.

Long-term outcome of biopsy-proven lupus nephritis in Iran.

Fatemi A, Kazemi M, Sayedbonakdar Z, Farajzadegan Z, Karimzadeh H, Moosavi M.

Int J Rheum Dis. 2013 Dec;16(6):739-46. doi: 10.1111/1756-185X.12228. Epub 2013 Nov 25.

PMID:
24267776
7.

The outcome and a new ISN/RPS 2003 classification of lupus nephritis in Japanese.

Yokoyama H, Wada T, Hara A, Yamahana J, Nakaya I, Kobayashi M, Kitagawa K, Kokubo S, Iwata Y, Yoshimoto K, Shimizu K, Sakai N, Furuichi K; Kanazawa Study Group for Renal Diseases and Hypertension.

Kidney Int. 2004 Dec;66(6):2382-8.

8.

The value of repeat biopsy in the management of lupus nephritis: an international multicentre study in a large cohort of patients.

Pagni F, Galimberti S, Goffredo P, Basciu M, Malachina S, Pilla D, Galbiati E, Ferrario F.

Nephrol Dial Transplant. 2013 Dec;28(12):3014-23. doi: 10.1093/ndt/gft272. Epub 2013 Aug 24.

PMID:
23975838
9.

Outcome of lupus nephritis in childhood onset SLE in North and Central India: single-centre experience over 25 years.

Srivastava P, Abujam B, Misra R, Lawrence A, Agarwal V, Aggarwal A.

Lupus. 2016 Apr;25(5):547-57. doi: 10.1177/0961203315619031. Epub 2015 Dec 3.

PMID:
26637291
10.

Prognosis of proliferative lupus nephritis subsets in the Louvain Lupus Nephritis inception Cohort.

Vandepapelière J, Aydin S, Cosyns JP, Depresseux G, Jadoul M, Houssiau FA.

Lupus. 2014 Feb;23(2):159-65. doi: 10.1177/0961203313514623. Epub 2013 Dec 3.

PMID:
24300780
11.

Predictors of poor renal outcome in patients with biopsy-proven lupus nephritis.

Ayodele OE, Okpechi IG, Swanepoel CR.

Nephrology (Carlton). 2010 Jun;15(4):482-90. doi: 10.1111/j.1440-1797.2010.01290.x.

PMID:
20609103
12.

Prognostic factors in lupus nephritis: diagnostic and therapeutic delay increases the risk of terminal renal failure.

Faurschou M, Starklint H, Halberg P, Jacobsen S.

J Rheumatol. 2006 Aug;33(8):1563-9.

PMID:
16881113
13.

Revised classification of lupus nephritis is valuable in predicting renal outcome with an indication of the proportion of glomeruli affected by chronic lesions.

Hiramatsu N, Kuroiwa T, Ikeuchi H, Maeshima A, Kaneko Y, Hiromura K, Ueki K, Nojima Y.

Rheumatology (Oxford). 2008 May;47(5):702-7. doi: 10.1093/rheumatology/ken019. Epub 2008 Apr 4.

PMID:
18390590
14.

Value of a complete or partial remission in severe lupus nephritis.

Chen YE, Korbet SM, Katz RS, Schwartz MM, Lewis EJ; Collaborative Study Group.

Clin J Am Soc Nephrol. 2008 Jan;3(1):46-53. Epub 2007 Nov 14.

15.

Outcome of reclassification of World Health Organization (WHO) class III under International Society of Nephrology-Renal Pathology Society (ISN-RPS) classification: retrospective observational study.

Hwang J, Kim HJ, Oh JM, Ahn JK, Lee YS, Lee J, Kim YG, Huh WS, Seo J, Koh EM, Cha HS.

Rheumatol Int. 2012 Jul;32(7):1877-84. doi: 10.1007/s00296-011-1887-x. Epub 2011 Mar 27.

PMID:
21442173
16.

Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis.

Conlon PJ, Fischer CA, Levesque MC, Smith SR, St Clair EW, Allen NB, Fleming JA, Howell DN.

Clin Nephrol. 1996 Sep;46(3):170-5.

PMID:
8879851
17.

Lupus nephritis in children and adolescents: results of the Italian Collaborative Study.

Ruggiero B, Vivarelli M, Gianviti A, Benetti E, Peruzzi L, Barbano G, Corona F, Ventura G, Pecoraro C, Murer L, Ghiggeri GM, Pennesi M, Edefonti A, Coppo R, Emma F.

Nephrol Dial Transplant. 2013 Jun;28(6):1487-96. doi: 10.1093/ndt/gfs589. Epub 2013 Jan 22.

PMID:
23345627
18.

Renal involvement in systemic lupus erythematosus. A study of 180 patients from a single center.

Huong DL, Papo T, Beaufils H, Wechsler B, Blétry O, Baumelou A, Godeau P, Piette JC.

Medicine (Baltimore). 1999 May;78(3):148-66.

19.

Lupus nephritis in Southern Chinese patients: clinicopathologic findings and long-term outcome.

Mok CC, Wong RW, Lau CS.

Am J Kidney Dis. 1999 Aug;34(2):315-23.

PMID:
10430980
20.

[Laboratory and morphologic parameters in patients with lupus nephritis].

Rasković S, Bogić M, Perić-Popadić A, Stefanović L, Arandjelović S, Jovicić Z, Bolpacić J, Tomić-Spirić V.

Srp Arh Celok Lek. 2002 Aug;130 Suppl 3:38-41. Serbian.

PMID:
12583312

Supplemental Content

Support Center